Merck

Merck
Author: Megan A. Sasso
Publisher:
Total Pages: 88
Release: 2001
Genre: Drugs
ISBN:

Prescribing by Numbers

Prescribing by Numbers
Author: Jeremy A. Greene
Publisher: JHU Press
Total Pages: 337
Release: 2007-02-15
Genre: Business & Economics
ISBN: 0801884772

Physician-historian Jeremy A. Greene examines the mechanisms by which drugs and chronic disease categories define one another within medical research, clinical practice, and pharmaceutical marketing, and he explores how this interaction has profoundly altered the experience, politics, ethics, and economy of health in late-twentieth-century America.

Innovation and Marketing in the Pharmaceutical Industry

Innovation and Marketing in the Pharmaceutical Industry
Author: Min Ding
Publisher: Springer Science & Business Media
Total Pages: 763
Release: 2013-10-31
Genre: Medical
ISBN: 1461478014

The pharmaceutical industry is one of today’s most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders (from investors to doctors), multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. In this volume, the editors showcase contributions from experts around the world to capture the state of the art in research, analysis, and practice, and covering the full spectrum of topics relating to innovation and marketing, including R&D, promotion, pricing, branding, competitive strategy, and portfolio management. Chapters include such features as: · An extensive literature review, including coverage of research from fields other than marketing · an overview of how practitioners have addressed the topic · introduction of relevant analytical tools, such as statistics and ethnographic studies · suggestions for further research by scholars and students The result is a comprehensive, state-of-the-art resource that will be of interest to researchers, policymakers, and practitioners, alike.

Competition in the 21st Century

Competition in the 21st Century
Author: Kirk Tyson
Publisher: CRC Press
Total Pages: 302
Release: 2024-11-01
Genre: Business & Economics
ISBN: 104027742X

Business competition will change radically in the next century. Short-sighted companies will go out of business. Survivors will successfully transition from the so-called Information Age of this century to the Intelligence Age of the 21st Century. Ten years in the making, this book paints competition of the future based on in-depth research of worldwide business over the past 100 years. By analogy, it shows business competition in its 19th-Century childhood, 20th-Century adolescence, and 21st-Century adulthood. The book highlights new beginnings - the Intelligence Age, highly networked "MegaStrategic Business Entities," and the need for both a "Competitive Knowledge Base" and "Perpetual Strategy Process" to provide an early warning system for executives. This is must-reading for business executives, managers and everyday consumers who want to plot a successful course for the future. It is also an invaluable reference tool for educators guiding the business leaders of tomorrow.

Real Options

Real Options
Author: Lenos Trigeorgis
Publisher: MIT Press
Total Pages: 452
Release: 1996-03-14
Genre: Business & Economics
ISBN: 9780262201025

Comprehensive in scope, Real Options reviews current techniques of capital budgeting and details an approach (based on the pricing of options) that provides a means of quantifying the elusive elements of managerial flexibility in the face of unexpected changes in the market. In the 1970s and the 1980s, developments in the valuation of capital-investment opportunities based on options pricing revolutionized capital budgeting. Managerial flexibility to adapt and revise future decisions in order to capitalize on favorable future opportunities or to limit losses has proven vital to long-term corporate success in an uncertain and changing marketplace. In this book Lenos Trigeorgis, who has helped shape the field of real options, brings together a wealth of previously scattered knowledge and research on the new flexibility in corporate resource allocation and in the evaluation of investment alternatives brought about by the shift from static cash-flow approaches to the more dynamic paradigm of real options—an approach that incorporates decisions on whether to defer, expand, contract, abandon, switch use, or otherwise alter a capital investment. Comprehensive in scope, Real Options reviews current techniques of capital budgeting and details an approach (based on the pricing of options) that provides a means of quantifying the elusive elements of managerial flexibility in the face of unexpected changes in the market. Also discussed are the strategic value of new technology, project interdependence, and competitive interaction. The ability to value real options has so dramatically altered the way in which corporate resources are allocated that future textbooks on capital budgeting will bear little resemblance to those of even the recent past. Real Options is a pioneer in this area, coupling a coherent picture of how option theory is used with practical insights in into real-world applications.

CIO

CIO
Author:
Publisher:
Total Pages: 90
Release: 1993-10-15
Genre:
ISBN:

Ethics and the Business of Bioscience

Ethics and the Business of Bioscience
Author: Margaret L. Eaton
Publisher: Stanford University Press
Total Pages: 556
Release: 2004
Genre: Medical
ISBN: 9780804742504

Businesses that produce bioscience products—gene tests and therapies, pharmaceuticals, vaccines, and medical devices—are regularly confronted with ethical issues concerning these technologies. Conflicts exist between those who support advancements in bioscience and those who fear the consequences of unfettered scientific license. As the debate surrounding bioscience grows, it will be increasingly important for business managers to consider the larger consequences of their work. This groundbreaking book follows industry research, development, and marketing of medical and bioscience products across a variety of fields, including biotechnology, pharmaceuticals, and bio-agriculture. Compelling and current case studies highlight the ethical decisions business managers frequently face. With the increasing visibility and public expectation placed on businesses in this sector, managers need to understand the ethical and social issues. This book addresses that need and provides a framework for incorporating ethical analysis in business decision making.